We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Blood Transfusions and Kidney Transplantation

Flavio Vincenti, MD; William J. C. Amend Jr, MD; Nicholas J. Feduska, MD; Oscar Salvatierra Jr, MD
Arch Intern Med. 1982;142(4):680-681. doi:10.1001/archinte.1982.00340170036005.
Text Size: A A A
Published online


In the past decade, great progress has been achieved in improving patient outcome following kidney transplantation. Patient mortality and morbidity have been greatly reduced with more specific and more limited immunosuppression regimens for the treatment of acute rejection.1 Excellent graft survival has also been predicted and obtained for patients who received kidneys from related HLA identical or 1-haplotype—-matched donors with low reactivity in the mixed lymphocyte cultures (MLCs).2 The majority of renal transplants, however, have used cadaver donor kidneys either because of the lack of available related donors or nonutilization of related donors because of high MLC reactivity between donor and recipient. Since graft survival rates in the patients with high MLCs are similar to those obtained with cadaveric transplantation,2,3 several newer techniques and approaches have been introduced to improve graft survival in these groups. Better donor-recipient matching through HLA DR typing and more specific immunosuppression with


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.